Literature DB >> 33119894

A Systematic Review of Interventions to Improve Mental Health and Substance Use Outcomes for Individuals with Prenatal Alcohol Exposure and Fetal Alcohol Spectrum Disorder.

Katherine Flannigan1, Kelly D Coons-Harding1,2, Tara Anderson3, Lindsay Wolfson1,4, Alanna Campbell5, Mansfield Mela1,6, Jacqueline Pei1,7,8.   

Abstract

Individuals with fetal alcohol spectrum disorder (FASD) experience remarkably high rates of mental health and substance use challenges, beginning early in life and extending throughout adulthood. Proactive intervention can help to mitigate some of these negative experiences. Although the literature on FASD intervention is growing, there is currently a lack of consolidated evidence on interventions that may improve mental health and substance use outcomes in this population. Informed by a life course perspective, we undertook a systematic review of the literature to identify interventions that improve mental wellness through all developmental stages for people with prenatal alcohol exposure (PAE) and FASD. A total of 33 articles were identified, most of which were focused on building skills or strategies that underlie the well-being of children with PAE and FASD and their families. Other interventions were geared toward supporting child and family wellness and responding to risk or reducing harm. There was a notable lack of interventions that directly targeted mental health and substance use challenges, and a major gap was also noted in terms of interventions for adolescents and adults. Combined, these studies provide preliminary and emerging evidence for a range of intervention approaches that may support positive outcomes for individuals with FASD across the life course.
© 2020 The Authors. Alcoholism: Clinical & Experimental Research published by Wiley Periodicals LLC on behalf of Research Society on Alcoholism.

Entities:  

Keywords:  Fetal Alcohol Spectrum Disorder; Intervention; Life Course; Mental Health; Prenatal Alcohol Exposure; Substance Use

Year:  2020        PMID: 33119894     DOI: 10.1111/acer.14490

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  6 in total

1.  Prenatal Exposure And Child brain and mental Health (PEACH) study: protocol for a cohort study of children and youth with prenatal alcohol exposure.

Authors:  Catherine A Lebel; W Ben Gibbard; Christina Tortorelli; Jacqueline Pei; Christian Beaulieu; Mercedes Bagshawe; Carly A McMorris
Journal:  BMJ Open       Date:  2021-05-11       Impact factor: 2.692

2.  Utilization of psychotropic medications in children with FASD: a retrospective review.

Authors:  Michael-Roy R Durr; Susan Petryk; Mansfield Mela; Andrea DesRoches; Mackenzie Wekerle; Sanjida Newaz
Journal:  BMC Pediatr       Date:  2021-11-16       Impact factor: 2.125

3.  Responding to the Unique Complexities of Fetal Alcohol Spectrum Disorder.

Authors:  Katherine Flannigan; Jacqueline Pei; Kaitlyn McLachlan; Kelly Harding; Mansfield Mela; Jocelynn Cook; Dorothy Badry; Audrey McFarlane
Journal:  Front Psychol       Date:  2022-01-25

4.  Efficacy and Feasibility of an Osteopathic Intervention for Neurocognitive and Behavioral Symptoms Usually Associated With Fetal Alcohol Spectrum Disorder.

Authors:  Ramon Cases-Solé; David Varillas-Delgado; Marta Astals-Vizcaino; Óscar García-Algar
Journal:  Front Behav Neurosci       Date:  2022-03-15       Impact factor: 3.558

5.  Suicidality and Associated Factors Among Individuals Assessed for Fetal Alcohol Spectrum Disorder Across the Lifespan in Canada.

Authors:  Katherine Flannigan; Carly McMorris; Amanda Ewasiuk; Dorothy Badry; Mansfield Mela; W Ben Gibbard; Kathy Unsworth; Jocelynn Cook; Kelly D Harding
Journal:  Can J Psychiatry       Date:  2021-11-05       Impact factor: 5.321

Review 6.  Prenatal and Postnatal Choline Supplementation in Fetal Alcohol Spectrum Disorder.

Authors:  Abigail M Ernst; Blake A Gimbel; Erik de Water; Judith K Eckerle; Joshua P Radke; Michael K Georgieff; Jeffrey R Wozniak
Journal:  Nutrients       Date:  2022-02-06       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.